History Repeats Itself - Trends in hallucinogen-associated emergency department visits and hospitalizations.

After more than two decades as a practicing psychiatrist, I’ll be the first to admit that we need new and innovative treatments to treat depression, anxiety, and other psychiatric disorders. Psychedelics like LSD, psilocybin, and MDMA (Ecstasy) are being researched and promoted as ground-breaking advances for combatting mental illness. Multiple jurisdictions have already relaxed laws or policies related to these substances, often with an eye toward therapeutic use.

Adolescent Residential Addiction Treatment In The US.

Several of our publications this week address the economics of addiction - supply, demand, and resources.

ASAM Weekly Top 10 News Publications of 2023

A year-in-review... Top 10 Peer-reviewed Scientific Publications of 2023.

As we start wrapping up 2023, the next two issues of The ASAM Weekly will contain the best of publications in both news and science. We do this each year to allow our readers an opportunity to catch up on things they may have missed, reflect on things that might have changed, or find out if they’re reading what their colleagues are reading (sort of like personalized normative feedback mentioned in the study from Alcohol Clinical and Experimental Research).

It takes big data to tackle some of the biggest issues in addiction. Cannabis use rates have been rising in recent years and a new study leveraging data from the largest integrated health care system in the US (the VA) has found that cannabis use disorder (CUD) rates have more than doubled among veterans. Unfortunately, increases were disproportionately found among veterans with psychiatric disorders, especially those with the most severe diagnoses such as bipolar and psychotic spectrum disorders (American Journal of Psychiatry).

The field of addiction medicine has been working hard to raise awareness about the disease and its treatments. A new study from NIDA researchers is doing so because of unfortunate findings: overdose deaths rose significantly for pregnant and postpartum women across demographic groups and in areas with adequate health care access, underscoring how stigma and punitive policies are still discouraging treatment (JAMA Psychiatry).

SAMHSA recently released results from the 2022 National Survey on Drug Use and Health (NSDUH). While further analysis of the data is expected to follow, many of our featured publications this week provide important context for the numbers.